Kolexia
Ousset Pierre Jean
Médecine générale
Cl Adolescence Villa Chu Tlse
Toulouse, France
131 Activités
340 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie d'Alzheimer Démence Symptômes prodromiques Troubles de la mémoire Fragilité Plaque amyloïde Atrophie Hypertension artérielle Amnésie

Industries

Roche
5 collaboration(s)
Dernière en 2022
Abbvie
4 collaboration(s)
Dernière en 2023
Biogen
1 collaboration(s)
Dernière en 2020
UCB
1 collaboration(s)
Dernière en 2021

Dernières activités

CELIA: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of BIIB080 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease Dementia
Essai Clinique (Biogen)   19 mars 2024
Drugs for Alzheimer's disease: Where are we coming from? Where are we going?
Science bulletin   23 février 2024
PROGRESS-AD: A Phase 2, Parallel Group, Randomized, Double- Blind, Placebo-Controlled, 3-Arm, Multicenter Treatment Study to Evaluate the Efficacy and Safety of GSK4527226 [AL101] Intravenous Infusion Compared With Placebo in Patients With Early Alzheimer's Disease
Essai Clinique (GSK)   12 février 2024
INSPIRE: The Inspire Bio-resource Research Platform for Healthy Aging
Essai Clinique (CHU Toulouse)   20 novembre 2023
Different Trajectories of Apathy and Depression Among Subjective Cognitive Impairment Individuals with or without Conversion to Dementia: Results from the Memento Cohort in France.
Journal of Alzheimer's disease : JAD   19 septembre 2023
Immunotherapies in Alzheimer's disease: state of the art and potential use in the elderly.
Geriatrie et psychologie neuropsychiatrie du vieillissement   01 août 2023
PERSON-AL: Personalized Management of Psycho-behavioral Symptoms in Alzheimer's Disease and Related Disorders: Impact on Health Resources Use
Essai Clinique (CHU Toulouse)   11 juillet 2023
Fatigue in Alzheimer's disease: biological basis and clinical management-a narrative review.
Aging clinical and experimental research   03 juillet 2023
The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint
The Lancet regional health. Europe   01 juin 2023
ALFA3pilot: Pilot Phase of a Prospective Cohort of Patients With Alzheimer's Disease and Their Families
Essai Clinique (CHU Toulouse)   20 avril 2023